This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1980 Aug;51(2):247-51.

doi: 10.1210/jcem-51-2-247.

Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?

S L Teitelbaum, M A Bergfeld, J Freitag, K A Hruska, E Slatopolsky

PMID: 6893204
DOI: 10.1210/jcem-51-2-247

Case Reports

Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?

S L Teitelbaum et al. J Clin Endocrinol Metab. 1980 Aug.

. 1980 Aug;51(2):247-51.

doi: 10.1210/jcem-51-2-247.

Authors

S L Teitelbaum, M A Bergfeld, J Freitag, K A Hruska, E Slatopolsky

PMID: 6893204
DOI: 10.1210/jcem-51-2-247

No abstract available

PubMed Disclaimer

Similar articles

Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
Brickman AS, Coburn JW, Sherrard DJ, Wong EG, Norman AW, Singer FR. Brickman AS, et al. Contrib Nephrol. 1980;18:29-41. doi: 10.1159/000403271. Contrib Nephrol. 1980. PMID: 7353378 No abstract available.
Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
Malluche HH, Goldstein DA, Massry SG. Malluche HH, et al. Contrib Nephrol. 1980;18:98-104. doi: 10.1159/000403277. Contrib Nephrol. 1980. PMID: 7353383 No abstract available.
Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
Sherrard DJ, Coburn JW, Brickman AS, Singer FR, Maloney N. Sherrard DJ, et al. Contrib Nephrol. 1980;18:92-7. doi: 10.1159/000403276. Contrib Nephrol. 1980. PMID: 7353382 No abstract available.
The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
Voigts AL, Felsenfeld AJ, Llach F. Voigts AL, et al. Arch Intern Med. 1983 Jun;143(6):1205-11. Arch Intern Med. 1983. PMID: 6344827 Review.
Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
Brickman AS, Coburn JW, Norman AW, Massry SG. Brickman AS, et al. Am J Med. 1974 Jul;57(1):28-33. doi: 10.1016/0002-9343(74)90764-5. Am J Med. 1974. PMID: 4600292 Review. No abstract available.

See all similar articles

Cited by

Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy.
Weinstein RS. Weinstein RS. Calcif Tissue Int. 1982 Jan;34(1):16-20. doi: 10.1007/BF02411202. Calcif Tissue Int. 1982. PMID: 6802455
Focal mineralization defect during disodium etidronate treatment of calcinosis.
Weinstein RS. Weinstein RS. Calcif Tissue Int. 1982 May;34(3):224-8. doi: 10.1007/BF02411241. Calcif Tissue Int. 1982. PMID: 6809282
Renal osteodystrophy.
Sundaram M. Sundaram M. Skeletal Radiol. 1989;18(6):415-26. doi: 10.1007/BF00368608. Skeletal Radiol. 1989. PMID: 2683115 Review. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems